The relationship between apolipoprotein E and serum oxidation related variables is apolipoprotein E phenotype dependent

被引:45
作者
Smith, JD
Miyata, M
Poulin, SE
Neveux, LM
Craig, WY
机构
[1] Fdn Blood Res, Scarborough, ME 04070 USA
[2] Rockefeller Univ, New York, NY 10021 USA
关键词
apolipoprotein E; phenotype; oxidation; lipid peroxides; ceruloplasmin;
D O I
10.1007/s005990050030
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
To examine the relationship between apolipoprotein E and serum oxidation status, we assayed apolipoprotein E level, apolipoprotein E phenotype, and levels of lipid peroxides and transition metal ions and their binding proteins in sera from apparently healthy individuals. The study group included 129 women aged 22-63 years and 53 men aged 22-56 years. Among subjects with apolipoprotein E 4/3 phenotype, lipid peroxide levels were higher compared with E 3/2 phenotype (786+/-182 nmol/l vs. 659+/-174 nmol/l, P=0.015), and ceruloplasmin levels were slightly higher compared with apolipoprotein E 3/3 phenotype (0.28+/-0.08 mg/l vs. 0.26+/-0.06 mg/l, P=0.035). In the study group as a whole, there were significant associations between serum apolipoprotein E level, and serum levels of ceruloplasmin (r=0.266, P<0.001) and ferritin (r=0.2, P<0.007). Among subjects with apolipoprotein E 4/3 phenotype, there was a significant association between serum apolipoprotein E and lipid peroxide levels (r=0.470, P<0.01), which was not apparent among subjects with E 3/3 or E 3/2 phenotypes. In multivariate analysis, apolipoprotein E phenotype was a small but significant independent contributor to variation in serum lipid peroxide levels. These data suggest that there may be heterogeneity among apolipoprotein E phenotypes in their relationships with serum lipid oxidation status.
引用
收藏
页码:116 / 121
页数:6
相关论文
共 37 条
[1]  
BOERWINKLE E, 1988, AM J HUM GENET, V42, P104
[2]   PRELIMINARY-STUDY OF AN INCREASE OF A PLASMA APOLIPOPROTEIN-E VARIANT ASSOCIATED WITH PERIPHERAL-NERVE DAMAGE - A FINDING IN PATIENTS WITH CHRONIC SPINAL PAIN [J].
CAMERON, BM ;
VANDERPUTTEN, DM ;
MERRIL, CR .
SPINE, 1995, 20 (05) :581-589
[3]  
Chait A, 1992, CURR OPIN LIPIDOL, V3, P389
[4]   GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES [J].
CORDER, EH ;
SAUNDERS, AM ;
STRITTMATTER, WJ ;
SCHMECHEL, DE ;
GASKELL, PC ;
SMALL, GW ;
ROSES, AD ;
HAINES, JL ;
PERICAKVANCE, MA .
SCIENCE, 1993, 261 (5123) :921-923
[5]   OXIDATION-RELATED ANALYTES AND LIPID AND LIPOPROTEIN CONCENTRATIONS IN HEALTHY-SUBJECTS [J].
CRAIG, WY ;
POULIN, SE ;
PALOMAKI, GE ;
NEVEUX, LM ;
RITCHIE, RF ;
LEDUE, TB .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1995, 15 (06) :733-739
[6]  
DONG LM, 1994, J BIOL CHEM, V269, P22358
[7]   INTACT HUMAN CERULOPLASMIN OXIDATIVELY MODIFIES LOW-DENSITY-LIPOPROTEIN [J].
EHRENWALD, E ;
CHISOLM, GM ;
FOX, PL .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (04) :1493-1501
[8]  
HARDARDOTTIR I, 1994, LYMPHOKINE CYTOK RES, V13, P161
[9]   INCREASED PLASMA AND LIPOPROTEIN LIPID-PEROXIDATION IN APO E-DEFICIENT MICE [J].
HAYEK, T ;
OIKNINE, J ;
BROOK, JG ;
AVIRAM, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 201 (03) :1567-1574
[10]   12-PROTEIN IMMUNOASSAY PROFILE ON THE COBAS FARA [J].
HUDSON, GA ;
POULIN, SE ;
RITCHIE, RF .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1987, 1 (02) :191-197